Capital Research & Management Co has recently announced that it has increased stake in Grifols S.A. (NASDAQ:GRFS) by 8.56%. After grabbing 19.4 million shares, the institutional investor is now in possession of 1.53 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 7.42% having worth around $168.0 million. Moreover, Millennium Management LLC increased its share by 3.15 million to have a control over 9.51 million shares. And Flat Footed LLC raised its holdings to 2.34 million shares by acquiring 7.94 million shares or 3.04% of the stake.
Grifols S.A. (GRFS) concluded trading on 03/16/23 at a closing price of $6.87, with 2.18 million shares of worth about $15.0 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -16.63% during that period and on Thursday the price saw a loss of about -7.79%. Currently the company’s common shares owned by public are about 256.23M shares, out of which, 135.24M shares are available for trading.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
American Funds New Perspective Fu, First Trust NYSE Arca Biotechnolo, and American Funds International Grow are the top 3 mutual funds which are holding stakes in Grifols S.A. American Funds New Perspective Fu is currently holding 13.38 million shares of worth totaling $115.87 million. The company recently came buying 1.26 million shares which brought its stake up to 5.12% of the company’s outstanding shares. American Funds International Grow, after buying 4.0 million shares, have now control over 1.53% of the stake in the company. It holds 0.0 shares of worth $34.66 million.
Grifols S.A. (NASDAQ: GRFS) started trading at $6.92, below -$0.53 from concluding price of the previous day. However, the stock later moved at a day high price of 7.00, or with a loss of -7.79%. Stock saw a price change of -9.84% in past 5 days and over the past one month there was a price change of -29.39%. Year-to-date (YTD), GRFS shares are showing a performance of -19.18% which decreased to -35.91% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $5.71 but also hit the highest price of $13.34 during that period. The average intraday trading volume for Grifols S.A. shares is 940.62K. The stock is currently trading -21.30% below its 20-day simple moving average (SMA20), while that difference is down -24.33% for SMA50 and it goes to -21.99% lower than SMA200.
Capital Research & Management Co acquired 19.4 million shares of Grifols S.A. having value of about $168.0 million. Data submitted at the U.S SEC by Capital Research & Management Co revealed that the firm now holds 1.53 million shares in the company valued at close to $10511635.86, or have control over 8.56% stake in the company. Grifols S.A. (NASDAQ: GRFS) currently have 256.23M outstanding shares and institutions hold larger chunk of about 42.60% of that. Holding of mutual funds in the company is about 20.69% while other institutional holders and individual stake holders have control over 21.46% and — of the stake respectively.
The stock has a current market capitalization of $5.96B and its 3Y-monthly beta is at 0.44. PE ratio of stock for trailing 12 months is 68.70, while it has posted earnings per share of $0.10 in the same period. Its PEG reads 5.57 and has Quick Ratio of 0.90 while making debt-to-equity ratio of 1.56. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for GRFS, volatility over the week remained 3.90% while standing at 4.54% over the month.
Stock’s fiscal year EPS is expected to drop by -71.10%. EPS is likely to grow at an annualized rate of 12.33% for next 5-years, compared to annual growth of 2.78% made by the stock over the past 5-years.
Stock get a Hold rating from Deutsche Bank on November 05, 2021.
Leave a Reply